BioVaxys Technology Corp. is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is...
NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, announced it has received approval from the Italian Medicines Agency (AIFA) to commence...
Ardelyx, Inc. , a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs,...
YS Biopharma Co., Ltd., a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics, announced that...
